Casey Harrell, a man with amyotrophic lateral sclerosis (ALS), is the first to extensively use a brain implant to communicate by translating neural activity into speech, marking a major step forward in assistive technology.
- Harrell has used the implant for over 3,800 hours independently at home.
- The brain implant translates neural signals into phonemes, enabling speech.
- Device operation has been simplified for everyday use with caregiver assistance.
What happened
Casey Harrell, diagnosed with ALS and paralyzed, had four arrays of electrodes implanted in his brain in July 2023 during a five-hour surgery. These electrodes target the speech motor cortex, a brain region that controls the movements necessary for speaking. The implant is connected externally via two docking stations on his skull, linking brain signals to a computer system that converts neural data into spoken words.
Shortly after the surgery, Harrell was able to use the brain-computer interface (BCI) to communicate with a vocabulary that began with 50 words and has since expanded to 125,000 words, achieving over 97% accuracy. Over nearly two years, he has independently used the device for thousands of hours at home, enabling him to not only speak but also surf the web and work.
Why it matters
This milestone represents a significant advancement in assistive communication technology for people with severe paralysis and speech loss due to neurological diseases like ALS. Unlike previous BCI trials requiring researcher intervention, Harrell can now operate the system largely on his own with help only for setup, greatly enhancing his autonomy and quality of life.
The device’s high accuracy in decoding brain signals corresponding to phonemes and turning them into speech paves the way for broader adoption and further development of speech BCIs. These systems could profoundly impact many individuals who are otherwise unable to communicate, offering renewed agency and social interaction.
What to watch next
Researchers will monitor the long-term durability and functionality of the implant to address challenges such as scar tissue development around electrodes, which can hinder signal detection. Improvements in hardware and decoding algorithms will also be critical to increase ease of use and vocabulary expansion.
Additionally, efforts to automate and simplify the connection process to enable fully independent daily use will be key to scalability. Further trials with more patients are expected to validate the technology’s value, usability, and commercial potential for everyday environments beyond clinical settings.